Home › Funds › Citigroup Inc › OCX
Citigroup Inc position in OCX
ONCOCYTE CORP
Latest position (Q1 2023)137 sh
Reported value held$49
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 6.85K | $24.00K | New |
| Q4 2021 | 18.28K | $39.00K | Add |
| Q1 2022 | 4.29K | $6.00K | Reduce |
| Q2 2022 | 3.52K | $3.00K | Reduce |
| Q3 2022 | 872 | $1.00K | Reduce |
| Q4 2022 | 1.05K | $309 | Add |
| Q1 2023 | 137 | $49 | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.